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Original article
Under-report and underdiagnosis of chronic respiratory diseases in
an African country
Chronic respiratory diseases (CRD), including chronic
obstructive pulmonary disease (COPD), constitute a
serious public health problem in all countries, particularly
in developing countries (1). Chronic respiratory diseases
are often under-reported and underdiagnosed (2, 3). This
is the case of COPD, which is usually undiagnosed until it
becomes clinically apparent and moderately advanced (4).
According to the type of deﬁnition used, COPD preva-
lence has been estimated to range from 4% to 20% in
adults over 40 years of age (5, 6) with a considerable
increase with age, particularly among smokers. COPD,
nevertheless, may also occur in people aged 20–44 years
(7). In a meta-analysis, the pooled prevalence of COPD
was 7.6% (6.4% for chronic bronchitis and 1.8% for
emphysema). The prevalence from spirometric estimates
was 8.9% (8).
Chronic obstructive pulmonary disease may be less
common in developing countries because of younger
populations and lower tobacco consumption compared
with industrialized countries (9). Tobacco smoking is the
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forced expiratory volume (FEV1) <80% of the predicted value and FEV1/forced
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Results: A total of 274 individuals with a satisfactory spirometry were included.
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association with airways obstruction. Smoking was a risk factor for a lower
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diagnosis, our results reinforce the need of performing a spirometry.
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single most important factor in the genesis of COPD and
is responsible for more than 75% of cases worldwide (10).
However, there is a link between COPD and biomass fuel
combustion, which is largely used in developing coun-
tries.
Data on CRD and related risk factors are scarce in
most developing countries, particularly in sub-Saharan
Africa. Diagnosis of CRD in developing countries is not a
simple process. Tests like spirometry are not readily
available, thus resulting in incorrect assessment, under-
diagnosis and consequent undertreatment (1).
Cape Verde (CV) Republic is an African country
located in the Gulf of Guinea. Cape Verde is a middle
income country that ranks the position 102 in the Human
Development Index 2007 (11). It is comprised of 10
islands with a total area of 4033 km2 for a total of
0.5 million people. Santiago is the largest island and it
has about 236000 inhabitants. Sa˜o Vincente it is the
seventh largest and the second most populated island
with 67000 inhabitants (census of 2000). The prevalence
of asthma in children is around 10% (12) and there are no
published data for other CRD.
We carried out a cross-sectional study in October 2006
in these two islands in order to assess the occurrence of
COPD, as deﬁned on the basis of various spirometric
standardized criteria and reported CRD by estimating
their point prevalence during 2 weeks, and to identify risk
factors associated with them. We studied a sample of
individuals seeking for health care at the Primary Health
Care (PHC) level and the Emergency Room (ER)
Departments during 2 weeks.
Methods
Procedures
The survey was conducted according to a protocol implemented
by Isabella Annesi-Maesano, Paolo Matricardi and
Nikolai Khaltaev in the frame of the Global Alliance Against
Chronic Respiratory Diseases (GARD) (a short version is
included as Annex 1). It consisted of the administration of a
standardized questionnaire (GARD pilot study, Portuguese
translation for CV) followed by a lung function assessment in a
sample of individuals. This study constitutes the ﬁrst application
of this protocol and deals more particularly with the spirometric
data.
The target population was constituted by outpatients older than
20 years seeking care at PHC level and ER in Santiago and
Sa˜o Vicente islands during 2 weeks, independently of their
complaint. All the PHC of Santiago and Sa˜o Vicente islands were
prepared previously by the CV GARD team. From 14 PHC, 12 (10
in Santiago and two in Sa˜o Vicente) and two ER departments
(one in each island) participated in the study. Two PHC did not
participate because of diﬃculty in accessing.
Questionnaire
The questionnaire was derived from the Burden of Obstructive
Lung Disease (BOLD) study questionnaire (13). It was translated
from English to Portuguese, and then back-translated to ascertain
accuracy. The staﬀ those who distributed the questionnaire were
trained and certiﬁed. It included questions about respiratory
symptoms and diseases, risk factors (smoking history, type of
cooking…), practice of respiratory-related health care and limita-
tion of activities. It was administered in the waiting room by an
interviewer (doctor or nurse) prior to the medical visit and collected
by the general practitioner at the end of the consultation. The
interviewer read clearly all the questions and repeated it in the case
the patient did not understand it. If the patient did not know a
term, a negative answer was assumed.
According to the standardized deﬁnition, chronic bronchitis was
deﬁned as the presence of cough and sputum production for at least
3 months in each of two consecutive years. Asthma, emphysema,
tuberculosis were deﬁned on the basis of the presence of a medical
diagnosis (Has a doctor ever told you that you had…). Smoking
was deﬁned as more than 20 packs of cigarettes or 12 oz of tobacco
in a lifetime or at least one cigarette a day for 1 year. A current
smoker was considered for those who smoked during the last
30 days. Occupational exposure was assumed for those who have
ever worked for a year or more in any dusty job. Patients job at the
time of the questionnaire was also enquired. Open ﬁre exposure was
considered for aﬃrmative answers to the question Do you cook
using an open ﬁre. Lastly, living in an urban region (city) was
separated by living in a rural region.
Spirometry
After the questionnaire, a spirometry was performed on the same
day using a portable pneumotachograph (Vitalograph Compact,
Vitalograph, Buckingham, UK) according to standardized guide-
lines (14). All the examinations were performed by a trained oper-
ator and under the supervision of a Pneumologist or Allergologist.
ECCC/ERS (European Community for Steel and Coal/European
Respiratory Society) reference equations (15) were used in the
population studied to assess the predicted values as we have used it in
previous visits to CV under the collaboration program of the Health
Ministries of Portugal and CV, within the frame of Chronic
Respiratory Diseases. Ethnic group adjustment was perfomed for
non-Caucasian individuals. Calibration was checked daily with a 3-L
syringe. Participants did up to eight forced expiratory manoeuvres to
obtain three acceptable manoeuvres, with forced vital capacity
(FVC) and forced expiratory volume (FEV1) reproducible within
150 ml. All spirometric examinations were performed with the
person seated, wearing a nose clip and a disposable mouthpiece.
Two criteria for airways obstruction were taken in account: an
FEV1 < 80% (16) of the predicted value and FEV1/FVC
ratio < 0.70 (17). Furthermore, the severity of airways obstruction
was deﬁned according to the Global Initiative for Chronic
Obstructive Lung Disease (GOLD) initiative (17) as follows: Stage 0
– chronic symptoms and normal spirometry; Stage I –
FEV1/FVC < 0.70 and FEV1 ‡ 80% predicted; Stage II –
FEV1/FVC < 0.70 and 50% £ FEV1 < 80% predicted;
Stage III – FEV1/FVC < 0.70 and 30% £ FEV1 < 50% pre-
dicted; Stage IV – FEV1/FVC < 0.70 and FEV1 < 30% predicted.
Statistical analysis
An exploratory analysis of the variables of interest was carried out
[sex, age, Body Mass Index (BMI), smoking status, occupation,
living in an urban vs rural area, occupational exposure and domestic
fuel exposure]. The occurrence of asthma, chronic bronchitis,
emphysema and tuberculosis (point prevalence) and the mean value
of the spirometric variables were estimated in the sample.
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Frequencies, percentages and means were calculated using classical
statistics (18). The chi-squared test was used to compare propor-
tions. The t-test analysis and the Mann–Whitney were used to
compare mean values in diﬀerent groups. A univariate study was
performed to calculate the crude odds ratios of the associations
between two variables. Adjusted odds ratios and corresponding
conﬁdence intervals were obtained as a result of ﬁtting a multivar-
iate logistic regression model to the data. Cohens Kappa coeﬃcient
was used to measure the agreement between the clinical status
reported by the participants and the spirometric classiﬁcation.
According to the literature, agreement was classiﬁed as follows:
<0: no agreement, 0–0.2: slight, 0.21–0.40: fair, 0.41–0.60:
moderate, 0.61–0.80: good and 0.80–1.00: excellent (19). The level of
signiﬁcance considered was a = 0.05, although P values greater
than 0.05 and lower than 0.1 were still reported to indicate trends.
spss (Statistical Package for the Social Sciences, 15.0; Chicago, IL,
USA) for Windows was used to analyse the data.
Results
A total of 314 individuals older than 20 years answered
the questionnaire and 274 (87.2%) were subjected to
spirometry. Seventy-ﬁve per cent were performed
in Santiago island, which respect the proportion of the
population among the islands. Women outnumbered men
in both islands in a high proportion than the real
demographic distribution (51.6% of women in the
whole population of CV). The description of the
sample is presented in Table 1. Forty individuals who
did not achieve a valid spirometry were younger
(41.5 ± 16.2 years vs 32.7 ± 14.8 years, P = 0.001).
No diﬀerence was found for gender, having a job, risk
factors and diseases. Table 2 presents spirometric mean
values in the sample. As expected, the FEV1 and FEV1/
FVC ratio declined with age.
In the 2 weeks of study, 10.9% were reported to suﬀer
from asthma (Table 3). 10.2% of individuals suﬀered
from chronic bronchitis, with men reaching 14.7%
compared with 7.9% of women. Men also suﬀered more
with emphysema than women, but the diﬀerence was not
statistically signiﬁcant (3.2% vs 1.7%). Tuberculosis
history was also more frequent in men (6.3% vs 1.7%
in women, P = 0.040).
In the 274 individuals with a satisfactory spirometry,
22% had an FEV1 < 80% and 8% FEV1/FVC < 0.70
(Table 3). FEV1 < 80% of the predicted value and
FEV1/FVC < 0.70 were more frequent in men than in
women, without reaching signiﬁcance. Based on the
Table 1. Description of the sample
Total Men Women P-value




38 [28–50] 43 [30–57] 36.5 [27–48] 0.017
20–45 years 179 53 126
‡46 years 95 43 52
BMI
Median [Q1–Q3] 24.1 [21.4–26.6] 24.0 [21.2–26] 23.8 [21.5–27] ns
Occupation
Have a job 163 (59.5%) 60 (63.2%) 103 (58.2%) ns
Smoking status
Never 240 (87.6%) 69 (71.9%) 171 (96.1%) <0.0001
Ex-smoker 18 (6.6%) 14 (14.6%) 4 (2.2%)
Current smoker 16 (5.8%) 13 (13.5%) 3 (1.7%)
Exposure to dust at workplace




124 (45.3%) 26 (27.0%) 98 (55.0%) <0.0001
BMI, Body Mass Index; Q1, first quartile; Q3, third quartile; ns, not significant.
Table 2. Mean values of age, percent predicted FEV1 and FEV1/FVC ratio (mean € SD)
Men Women
20–45 year ‡46 year Total 20–45 year ‡46 year Total
n 53 43 96 126 52 178
Age (years) 31.7 € 7.5 61.1 € 12.2 44.8 € 17.7 35.0 € 5.7 59.3 € 10.9 39.3 € 15.1
FEV1% 92.9 € 16.9* 85.5 € 22.8 89.7 € 19.2 95.7 € 14.34 86.8 € 24.3 92.7 € 18.2
FEV1/FVC 0.82 € 0.08 0.76 € 0.09 0.80 € 0.09 0.83 € 0.07 0.75 € 0.13 0.81 € 0.1
FVC, forced vital capacity; FEV1, forced expiratory volume in first second.
Analysis between age groups: *P = 0.063, P = 0.095, P < 0.0001; no differences for sex.
Table 3. Prevalence of major respiratory diseases and spirometric alterations
Total Men Women P-value
Asthma 30 (10.9%) 9 (9.5%) 21 (11.8%) ns
Chronic bronchitis 28 (10.2%) 14 (14.7%) 14 (7.9%) 0.075
Emphysema 6 (2.2%) 3 (3.2%) 3 (1.7%) ns
Tuberculosis 9 (3.3%) 6 (6.3%) 3 (1.7%) 0.040
Spirometric alterations
FEV1% < 80% predicted 60 (21.9% 26 (27.4%) 34 (19.1%) ns
FEV1/FVC < 0.70 23 (8.4%) 10 (10.5%) 13 (7.3%) ns
COPD GOLD
Stage 0 21 (7.7%) 10 (10.4%) 11 (6.1%) ns
Stage I 4 (1.5%) 2 (2%) 2 (1.1%) ns
Stage II 8 (2.9%) 4 (4.1%) 4 (2.2%) ns
Stage III 10 (3.6%) 4 (4.1%) 6 (3.3%) ns
Stage IV 1 (0.03%) 0 (0%) 1 (0.06%) ns
FVC, forced vital capacity; FEV1, forced expiratory volume in first second; COPD,
chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic
Obstructive Lung Disease; ns, not significant.
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severity of airways obstruction, most COPD patients
were classiﬁed as GOLD stage 0, followed by stage II and
stage III.
Asthma had a clear association with spirometric
criteria even after the adjustment for age and sex, thus
supporting the presence of severe stages of airways
obstruction on diagnosis (Table 4). This association was
higher for asthma than for chronic bronchitis. Emphy-
sema was associated with a low FEV1.
The agreement between CRD and airways obstruction
was generally poor. Indeed, for FEV1 and FEV1/FVC,
the Kappa values were 0.057 and 0.074 for chronic
bronchitis (no agreement), 0.085 and 0.014 for emphy-
sema (no agreement) and 0.053 and 0.064 for tuberculosis
(no agreement). The best agreement was reached for
asthma with the FEV1 getting a Kappa value of 0.281
(slight agreement).
Related factors
Individuals older than 46 years had a higher risk for
spirometric changes conﬁrming that age is a major risk
factor for airways obstruction (Table 5). No association
was found for BMI and region. After taking potential
confounders into account, current smoking was clearly
associated with a lower FEV1. Those older than
46 years had a higher risk for emphysema and asthma
(Table 6). Factors related to CRD were as follows:
smoking for chronic bronchitis, emphysema and asth-
ma. Exposure to dust at workplace was a risk factor
for chronic bronchitis and asthma. Cooking/heating
using an open ﬁre was associated with chronic bron-
chitis and asthma.
Discussion
Chronic respiratory diseases are one of the leading causes
of morbidity and mortality in the adult population
worldwide. Data from the World Health Organizations
Large Analysis and Review of European Housing and
Health Status Study conducted in random samples from
Table 4. Agreement table between respiratory diseases and spirometric changes
FEV1 < 80% FEV1/FVC < 0.70
No Yes No Yes
CB
No 193 53 226 20
Yes 21 7 25 3
OR 1.13 (0.44–2.90), P = 0.800 1.31 (0.34–5.05), P = 0.696
Emphysema
No 212 56 246 22
Yes 2 4 5 1
OR 4.99 (0.85–29.44), P = 0.076 1.07 (0.11–10.01), P = 0.950
Asthma
No 199 41 232 8
Yes 13 17 16 14
OR 5.93 (2.69–13.51), P = 0.000 25.02 (8.43–74.30), P = 0.000
Tuberculosis
No 209 54 242 21
Yes 4 5 7 2
OR 4.96 (1.23–20.04), P = 0.025 3.76 (0.64–22.05), P = 0.143
FVC, forced vital capacity; FEV1, forced expiratory volume in first second; CB, chronic bronchitis; OR, Odds ratio; CI, confidence interval.
Odds ratio (OR, CI 95%, P-value) presented concerns a multivariate analysis, adjusted for age and sex.
Table 5. Relationships between spirometric changes and risk factors, adjusted for
age and sex (multivariate analysis – OR, CI: 95%, P-value)
FEV1 < 80% FEV1/FVC < 0.70
Age
20–45 years 1 1
‡46 years 2.73 (1.52–4.92), P = 0.001 6.28 (2.38–16.55), P = 0.000
Sex
Men 1 1
Women 0.62 (0.34–1.12), P = 0.116 0.67 (0.28–1.59), P = 0.361
Smoking status
Never 1 1
Ex-smoker 1.64 (0.56–4.84), P = 0.370 2.28 (0.56–9.34), P = 0.253
Current smoker 3.10 (1.11–8.66), P = 0.031 3.21 (0.79–12.95), P = 0.102
Exposure to dust at workplace
No 1 1
Yes 1.07 (0.58–1.97), P = 0.828 0.91 (0.36–2.26), P = 0.834
Cooking/heating using open fire
No 1 1
Yes 1.67 (0.84–3.32), P = 0.146 0.85 (0.31–2.29), P = 0.743
FVC, forced vital capacity; FEV1, forced expiratory volume in first second; OR, Odds
ratio; CI, confidence interval.
For age and sex are presented crude OR.
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eight European cities showed that in the year preceding
the survey, 3.3% of individuals had been diagnosed or
treated for asthma and 6.2% for chronic bronchitis and
emphysema. One per cent suﬀered simultaneously from
both (20).
Spirometry is the gold standard for diagnosing and
monitoring the progression of obstructive lung diseases.
Spirometry is essential for COPD diagnosis and provides
a useful description of the severity. Speciﬁc spirometric
cut-points (postbronchodilator FEV1/FVC ratio < 0.70
or FEV1 < 80% predicted) are used for purposes of
simplicity (17). However, diﬀerences in the deﬁnition of
COPD in guidelines make it diﬃcult to quantify and to
make comparisons between countries.
In our study, we used a standardized questionnaire and
spirometric tests to identify airways obstruction and
CRD in outpatients seeking for health care in PHC.
Twenty two per cent of the individuals had an
FEV1 < 80%. Asthma diagnosis (11%) had a higher
agreement with obstruction according to spirometric
deﬁnitions than the presence of chronic bronchitis
(10%) or emphysema (2%), which could be because of
the fact that asthma was severe in our population.
Unfortunately, asthma severity was not assessed in our
population. The concomitant diagnosis of asthma,
chronic bronchitis or emphysema is common, particularly
in adults aged over 50 years (21, 22). The lack of
agreement between diseases and airways obstruction
could also be because of underreporting of the diseases
in our population.
In this study, association to asthma diagnosis was the
highest in those older than 46 years. The rates of an
asthma diagnosis found were well above the 4.5% median
value found for instance in the European Community
Respiratory Health Survey (ECRHS) (23). However, the
question used in this study (Have you ever been told by a
doctor…) was diﬀerent from the question used in
ECRHS that took in account the previous 12 months.
Yet, it was similar to the question used by Ehrlich in
South Africa, where a lower overall prevalence was found
(3.8%) (24).
It is important to make the distinction between
asthma and COPD, even in older patients, because their
optimal management must be based on diﬀerent
approaches (25). Diagnosis starts with speciﬁc training
of professionals at diﬀerent levels of the health care
system making it possible to identify conveniently the
symptoms and to develop programmes of prevention
and treatment. The distribution of the severity of
airways obstruction conﬁrms the lack of representative-
ness from the general population, although the data
were collected at PHC where we could ﬁnd more severe
stages.
As expected, smoking was clearly associated with
chronic bronchitis, emphysema and asthma, suggesting
a common factor for these diagnoses. Smoking was a risk
factor for tuberculosis infection as documented by other
authors (26). Exposure to a dust workplace and cooking
using an open ﬁre was associated with CRD, namely,
with chronic bronchitis and asthma. Those risk factors
seem also important for spirometric changes as tobacco
was related with most of the obstruction.
A ﬁrst limitation of our study is that only 274
individuals were included. However, they were the
outpatients of a representative sample of PHC during a
ﬁxed period. Thereafter, major biases can be excluded. In
CV, ERs are used by the population as PHC and that was
the reason to include it in the study. Another limitation of
our study is that we did not use the GOLD COPD
deﬁnition as no bronchodilator was administered. Cape
Verde is a country where tests like spirometry are not
readily available because of a lack of equipment and
Table 6. Relationships between chronic respiratory diseases and risk factors adjusted for age and sex (multivariate analysis – OR, CI: 95%, P-value)
Chronic bronchitis Emphysema Tuberculosis Asthma
Age
20–45 years 1 1 1 1
‡46 years 1.05 (0.47–2.38), P = 0.903 9.89 (1.14–85.92), P = 0.011 0.96 (0.24–3.93), P = 0.956 2.37 (1.10–5.11), P = 0.024
Sex
Men 1 1 1 1
Women 0.49 (0.23–1.08), P = 0.075 0.53 (0.10–2.66.08), P = 0.429 0.25 (0.62–1.03), P = 0.040 1.29 (0.57–2.94), P = 0.547
Smoking status
Never 1 1 1 1
Ex-smoker 1.56 (0.37–6.55), P = 0.547 20.01 (1.99–201.08), P = 0.011 0.97 (0.09–10.03), P = 0.982 0.44 (0.05–3.81), P = 0.459
Current smoker 2.84 (0,85–9.46), P = 0.09 7.38 (0.49–110.32), P = 0.147 0.96 (0.10–8.99), P = 0.974 3.30 (0.95–11.50), P = 0.061
Exposure to dust at workplace
No 1 1 1 1
Yes 2.24 (0.98–5.14), P = 0.056 2.38 (0.41–13.88), P = 0.336 1.40 (0.35–5.62), P = 0.633 2.17 (0.98–4.82), P = 0.057
Cooking/heating using open fire
No 1 1 1 1
Yes 3.51 (1.28–9.66), P = 0.015 0.24 (0.02–2.60), P = 0.239 0.99 (0.08–11.79), P = 0.995 2.48 (0.97–6.33), P = 0.057
OR, odds ratio; CI, confidence interval.
For age and sex are presented crude OR.
Chronic respiratory diseases in Cape Verde
 2009 The Authors
Journal compilation  2009 Blackwell Munksgaard Allergy 2009: 64: 1061–1067 1065
trained operators. For this reason we decided not to
perform the bronchodilator test. Thereafter, we have
studied the FEV1/FVC ratio, a parameter that is easily
measured and can be used without the need of reference
equations. The fact that in our sample an FEV1 < 80%
predicted was observed in more people than FEV1/
FVC < 0.70 could be explained in part by a lung
restrictive pattern in our participants. The results
achieved for FEV1 and its relation with CRD and
expositions make the results reliable.
Conclusions
Under-report and underdiagnosis of chronic respiratory
conditions seem to be a reality in CV, just as in other
parts of the world. To improve diagnosis, our results
reinforce the need of performing a spirometry as a routine
test. This will help the clinician to diagnose correctly a
CRD and to choose the most adequate treatment
according to severity of the disease.
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